What development phase is Ricobendazole in?

Ricobendazole is FDA-approved (marketed).

What is the generic name of Ricobendazole?

albendazole sulfoxide is the generic (nonproprietary) name of Ricobendazole.

Last reviewed 2026-04-20 · How we verify

Ricobendazole (albendazole sulfoxide)

FDA-approved active Quality 10/100

At a glance

Generic name	albendazole sulfoxide
Drug class	albendazole sulfoxide
Target	Tubulin alpha chain
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Safety and Efficacy Study of Different Doses of Oxfendazole Compared to a Single Dose of Albendazole to Treat Trichuris Trichiura Infection in Adults (PHASE2)
Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ricobendazole CI brief — competitive landscape report
Ricobendazole updates RSS · CI watch RSS
portfolio CI